PIM
HALO icon

Plato Investment Management’s Halozyme HALO Stock Holding History

Plato Investment Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,555
Closed -$101K – 536
2026
Q1 		$101K Sell
1,555
-702
-31% -$49.5K 0.01% 432
2025
Q4 		$153K Buy
+2,257
New +$152K 0.01% 404

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Plato Investment Management's HALO Position: Q2 2026 in Review

Plato Investment Management sold out of Halozyme (HALO) in Q2 2026, closing a stake of 1,555 shares — an estimated $101K sold.

Plato Investment Management first reported a position in HALO in Q4 2025 and held it in 2 quarters. The position peaked at $153K in Q4 2025. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Plato Investment Management reported no remaining Halozyme position as of Q2 2026 after selling out during the quarter.
  • Plato Investment Management sold 1,555 Halozyme shares in Q2 2026, an estimated $101K.
  • Plato Investment Management first reported a position in Halozyme in Q4 2025 and held it in 2 quarters.
  • Plato Investment Management's Halozyme position peaked at $153K in Q4 2025.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Plato Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.